Pharmaceutical Profiles (Nottingham, UK) is continuing to extend its key role in advancing inhaled medicines. Recent successes include the conclusion of drug deposition studies using scintigraphic imaging that have: supported the development of a novel breath-synchronized, plume-control inhaler (BSPCI), and demonstrated enhanced delivery of asthma and anti-migraine medications to the lungs.
